Keypoint is a Full Service Contract Research Organization, dedicated to the development and implementation of clinical trials, observacional studies, regestry studies, epidemiologic studies and health economics.
- Rigor
- Know-how
- Experience
- Independence
- Quality
Study distinguished by ISPOR

Tocilizumab Cost-Effectiveness study, was honored by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in the 14th Annual European Congress held November 5-8 in Madrid, the prize for the Best Research Presentations Poster Awards.
Português
English
